Cellular & Molecular Immunology

Papers
(The TQCC of Cellular & Molecular Immunology is 82. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron430
MHC class II in renal tubules plays an essential role in renal fibrosis416
No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1287
CAR-T cell therapy: new hope for systemic lupus erythematosus patients189
Systems-based approaches to study immunometabolism180
Immune regulation in the tumor microenvironment and its relevance in cancer therapy174
SRSF1 plays a critical role in invariant natural killer T cell development and function168
Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2158
Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins145
Group 2 innate lymphoid cells can engulf and destroy bacteria120
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells114
CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches111
Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells109
FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes108
Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases106
Resident and migratory adipose immune cells control systemic metabolism and thermogenesis106
Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice99
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency95
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy86
Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains86
Diet, lipids, and antitumor immunity85
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia83
Publisher Correction: Epitopes for a 2019-nCoV vaccine82
0.02245306968689